Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,276–3,300 of 7,816 matching trials · page 132 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION) NCT02615002 Piromelatine; Placebo Runs in: United States · 56 sites |
PHASE2 other |
COMPLETED | 371 | Neurim Pharmaceuticals Ltd. INDUSTRY |
2024-07-05 |
|
Playful Multimodal Intervention, Monitoring and Decision Support for Activation of People With Alzheimer's Dementia NCT04628702 tablet training Runs in: Austria · 1 site |
NA other |
COMPLETED | 24 | Medical University of Graz OTHER |
2024-07-05 |
|
Dronabinol for Agitation in Dementia Crossover Trial NCT05612711 Dronabinol Runs in: United States · 1 site |
PHASE2 other |
WITHDRAWN | 0 | Ralph H. Johnson VA Medical Center OTHER_GOV |
2024-07-05 |
|
Construction and Validation of Dementia Care Management Competency NCT06032351 Innovation-integrated curriculum for dementia care and care managem... Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 190 | Chang Gung Memorial Hospital OTHER |
2024-07-05 |
|
Virtual perI-/Menopause Registry of AusTrALia NCT06487130 N/A Observational Registry Runs in: Australia · 1 site |
NA other |
RECRUITING | 10,000 | Bespoke Clinical Research INDUSTRY |
2024-07-05 |
|
Dr Solitaire: Assessing Cognitive Performance Through Meaningful Play NCT02971124 Runs in: Belgium · 2 sites |
NA other |
UNKNOWN | 30 | Universitaire Ziekenhuizen KU Leuven OTHER |
2024-07-03 |
|
Phase IIa L-serine Trial for eAD NCT03062449 L-Serine; Placebo Gummy Runs in: United States · 1 site |
PHASE2 other |
TERMINATED | 29 | Aleksandra Stark OTHER |
2024-07-03 |
|
Deferiprone to Delay Dementia (The 3D Study) NCT03234686 Deferiprone 600mg delayed release tablets; Placebo Oral Tablet Runs in: Australia · 8 sites |
PHASE2 other |
COMPLETED | 81 | Neuroscience Trials Australia OTHER |
2024-07-03 |
|
Synaptic Density, Tau and Multiparametric PET-MR in Brain Trauma, Stroke and Mild Cognitive or Behavioral Impairment. NCT03514524 PET-MR imaging Runs in: Belgium · 1 site |
NA other |
UNKNOWN | 150 | Universitaire Ziekenhuizen KU Leuven OTHER |
2024-07-03 |
|
A Dyadic Telehealth Program for Alzheimer's Patients/Caregivers NCT05102565 sleep education program Runs in: United States · 1 site |
NA other |
COMPLETED | 29 | University of California, Los Angeles OTHER |
2024-07-03 |
|
Teleneuropsychological Intervention in Asymptomatic HIV Seropositive Patients: N&C NeuroChange NCT05571761 Cognitive stimulation program Runs in: Mexico · 1 site |
NA other |
WITHDRAWN | 0 | Universidad Nacional Autonoma de Mexico OTHER |
2024-07-03 |
|
Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease NCT05578443 10g Astragalus; Routine treatment; 20g Astragalus Runs in: China · 1 site |
PHASE2 other |
UNKNOWN | 66 | Fujian Medical University Union Hospital OTHER |
2024-07-03 |
|
Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS NCT05996575 fNIRS measurement Runs in: United States · 6 sites |
NA other |
COMPLETED | 133 | Kernel INDUSTRY |
2024-07-03 |
|
Environmental and Reproductive Health Risk for Lewy Body Dementia NCT06005935 Survey Runs in: United States · 1 site |
NA other |
UNKNOWN | 225 | University of California, San Diego OTHER |
2024-07-03 |
|
Virtual Reality Cognitive Training for Older Adults With Mild Cognitive Impairment NCT06392412 fi-VR Cognitive Training; Traditional Cognitive Training |
NA other |
NOT_YET_RECRUITING | 52 | Da-Yeh University OTHER |
2024-07-03 |
|
Goal Attainment Scaling (GAS) Sub-Study NCT06484426 Runs in: United States · 5 sites |
NA other |
COMPLETED | 46 | LuMind IDSC Foundation OTHER |
2024-07-03 |
|
Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease NCT02908815 rTMS active treatment; rTMS sham treatment Runs in: Australia; Canada · 3 sites |
NA other |
COMPLETED | 200 | University of Manitoba OTHER |
2024-06-28 |
|
Alzheimer's Disease and Precision Medicine Research Among Native People NCT03448601 Culturally tailored brochure intervention group; Culturally tailore... Runs in: United States · 1 site |
NA other |
COMPLETED | 523 | University of Colorado, Denver OTHER |
2024-06-27 |
|
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy NCT03860935 acoramidis; Placebo Oral Tablet Runs in: Australia; Belgium; Brazil; Canada; Czechia; Denmark; Gre... · 104 sites |
PHASE3 other |
COMPLETED | 632 | Eidos Therapeutics, a BridgeBio company INDUSTRY |
2024-06-27 |
|
TRC-PAD Program: In-Clinic Trial-Ready Cohort NCT04004767 Runs in: United States · 45 sites |
NA other |
COMPLETED | 220 | University of Southern California OTHER |
2024-06-27 |
|
Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome NCT04149197 Runs in: United States · 14 sites |
NA other |
TERMINATED | 252 | LuMind IDSC Foundation OTHER |
2024-06-27 |
|
A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia. NCT06217146 Medical Cannabis; Placebo Oil Runs in: Israel · 3 sites |
NA other |
TERMINATED | 24 | M. H MediCane Ltd. INDUSTRY |
2024-06-27 |
|
Blood Biomarkers for Screening of Alzheimer's Disease NCT06477484 Blood biomarker Runs in: China · 1 site |
NA other |
UNKNOWN | 180 | Peking University First Hospital OTHER |
2024-06-27 |
|
Memory Functions in Mild Alzheimer's Disease NCT04785053 transcranial alternating current stimulation (tACS) Runs in: United States · 1 site |
NA other |
COMPLETED | 34 | Hebrew SeniorLife OTHER |
2024-06-26 |
|
RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β NCT06470061 Resveratrol, Quercetin, and Curcumin (RQC); Curcumin Runs in: United States · 1 site |
PHASE2 other |
NOT_YET_RECRUITING | 200 | Zaparackas and Knepper LTD OTHER |
2024-06-26 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial